SEC Form D private-offering filing
Cadrenal Therapeutics, Inc.
A new SEC Form D private-offering notice from Ponte Vedra, FL, a $8,843,849 filer-stated offering target in Biotech. The source filing is one click away.
Late-stage biopharmaceutical company developing therapies for immune and thrombotic conditions, including tecarfarin, an oral anticoagulant in Phase 3 trials.
Filed 7 days agoFiled to raise $8,843,849First money in 2026-06-30Raised so far $8,843,849HQ (as filed) Ponte Vedra, FLSector Biotech ✓Stage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified cadrenal.com↗Named in the filing 7 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.